临床相关性:Treatment guidance

A total of 15 records found

#22039 high Confidence
Subject: radical_resection_postoperative_radiotherapy (Treatment options)
is_treatment_of_choice_for
Object: oncocytic_carcinoma (Tumor type)
Original: Radical resection postoperative radiotherapy#is#the treatment of choice for oncocytic carcinoma
🏥 Treatment guidance 📄 PMID: 23135197
#21862 high Confidence
Subject: ROS1_protein (Receptor tyrosine kinases)
identifies
Object: patients_suitable_for_molecular_targeted_therapy (Patient population)
Original: Immunocytochemical detection of ROS1 protein#helps identify#patients suitable for molecular targeted therapy
🏥 Treatment guidance 🧬 ROS1 📄 PMID: 29076659
#21684 high Confidence
Subject: Non-Wilms'_renal_malignant_neoplasm (Tumor type)
must_be_distinguished_from
Object: Wilms' tumor (Tumor type)
Original: Non-Wilms' renal malignant neoplasms#must be distinguished from#common Wilms' tumor for appropriate chemotherapy
🏥 Treatment guidance 📄 PMID: 15830360
#21367 high Confidence
Subject: next-generation_sequencing (Molecular detection technology)
is_recommended_to_identify
Object: MAPK/ERK_pathway_mutations_for_targeted_therapy (Molecular diagnostic markers)
Original: Next-generation sequencing#is recommended to identify#MAPK/ERK pathway mutations for targeted therapy
🏥 Treatment guidance 📄 PMID: 37167084
#20098 high Confidence
Subject: cytologic_grading (Cytological grading)
determines
Object: choice_of_therapy (Treatment options)
Original: combined histologic and cytologic grading of prostate carcinomas#determines#choice of therapy based on staging
🏥 Treatment guidance 📄 PMID: 2983471
#20097 high Confidence
Subject: histologic_grading (Histological grading)
determines
Object: choice_of_therapy (Treatment options)
Original: combined histologic and cytologic grading of prostate carcinomas#determines#choice of therapy based on staging
🏥 Treatment guidance 📄 PMID: 2983471
#18931 middle Confidence
Subject: Silver_staining_for_nucleolar_organizer_region (Molecular staining technology)
provides
Object: therapeutic_decision_information (Clinical decision information)
Original: Silver staining for nucleolar organizer region#provides#additional information for therapeutic decisions
🏥 Treatment guidance 📄 PMID: 9254998
#18357 middle Confidence
Subject: predictive_findings (Clinical predictors)
guides
Object: surgical_decision_making (Therapeutic interventions)
Original: Predictive findings#guide#surgical decision making
🏥 Treatment guidance 📄 PMID: 20025540
#18268 middle Confidence
Subject: preoperative_identification_of_poor_prognostic_variant_of_endometrial_carcinoma (Diagnostic Process)
may_influence
Object: choice_of_adjuvant_therapy (Treatment options)
Original: Preoperative identification of poor prognostic variant of endometrial carcinoma#may influence#surgical management and choice of adjuvant therapy
🏥 Treatment guidance 📄 PMID: 15716611
#18267 middle Confidence
Subject: preoperative_identification_of_poor_prognostic_variant_of_endometrial_carcinoma (Diagnostic Process)
may_influence
Object: surgical_management (Treatment options)
Original: Preoperative identification of poor prognostic variant of endometrial carcinoma#may influence#surgical management and choice of adjuvant therapy
🏥 Treatment guidance 📄 PMID: 15716611
#18253 middle Confidence
Subject: Cellular type of melanoma (Tumor cell type)
must_be_defined_to
Object: proper method of treatment (Treatment)
Original: Cellular type of melanoma#must be defined#to choose the proper method of treatment
🏥 Treatment guidance 📄 PMID: 6573087
#17547 middle Confidence
Subject: Salivary_gland_secretory_carcinoma (Tumor diseases)
treated_by
Object: complete_surgical_resection (Treatment)
Original: All patients#underwent#complete surgical resection and are alive without tumor recurrence
🏥 Treatment guidance 📄 PMID: 33459993
#17546 middle Confidence
Subject: Surgical_resection (Treatment)
is_mainstay_of
Object: treatment_for_sinonasal_renal_cell-like_adenocarcinoma (Treatment options)
Original: Surgical resection#is the mainstay of#treatment for sinonasal renal cell-like adenocarcinoma
🏥 Treatment guidance 📄 PMID: 33152820
#667 low Confidence
Subject: clinical_follow-up (Clinical management measures)
may_be_needed_for
Object: patients_with_microinvasive_carcinoma (Patient population)
Original: Closer clinical follow-up#may be needed for#patients with CIN3 associated with microinvasive carcinoma
🏥 Treatment guidance 📄 PMID: 7962647
#666 low Confidence
Subject: clinical_follow-up (Clinical management measures)
may_be_needed_for
Object: patients_with_CIN3 (Patient population)
Original: Closer clinical follow-up#may be needed for#patients with CIN3 associated with microinvasive carcinoma
🏥 Treatment guidance 📄 PMID: 7962647